A Study of the Cardiovascular Risk Factor Profile in Patients with Acute Coronary Syndrome with Particular Reference to Metabolic Syndrome

Mohammad Ali Sowdagar¹, Adikesava Naidu Otikunta^2*, Y. V. Subba Reddy², Chandra Sekhar Pulala¹

¹Department of Cardiology, Kurnool Medical College, Kurnool, India.
²Department of Cardiology, Osmania General Hospital and Osmania Medical College, Hyderabad, India.

DOI: 10.4236/ijcm.2015.611113                

Abstract

Objectives: Cardiovascular risk factors for acute coronary syndrome (ACS) are on rise in people of Indian origin. Moreover, the prevalence of metabolic syndrome (MS) is higher in populations with ACS than in the general population. Thus, the aim of the study was to evaluate the cardiovascular risk factor profile of patients presenting with acute coronary syndrome and to study the prevalence and impact of metabolic syndrome in patients with acute coronary syndrome by using South Asian modified National cholesterol Education Program Adult Treatment Panel III definition. Methods: This study was conducted between October, 2010 and March, 2011 at Government General Hospital, Kurnool, India. A total of 100 patients with ST or non-ST segment elevation ACS and who had clinical, electrocardiographic and biochemical diagnosis within the first 24 hrs of clinical onset were enrolled in the study. The enrolled subjects were divided into two groups: those with MS and those without MS. Cardiovascular risk factors defined by components of MS were evaluated. Analysis was performed using SPSS software. Results: Sixty patients had MS along with ACS and 40 patients had ACS without MS. The most prevalent component of MS was increased waist circumference (83.3%), followed by increased triglycerides (78.3%) and increased fasting blood sugar (76.7%). Majority of patients (58.3%) had presence of three components of MS. Conclusion: The MS is a highly prevalent condition among the patients with ACS and is associated with severe coronary artery disease. The identification of MS imparts a high risk status to the patient in developing cardiovascular disease but at the same time provides abundant opportunities for intervention. Hence it is of paramount importance to aim for stricter goals and lower cut offs for intervention at all levels of prevention: primordial, primary and secondary.

Keywords

Acute Coronary Syndrome, Coronary Artery Disease, Metabolic Syndrome

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Zargar, A.H. (2015) Type 1 Diabetes Guidelines: Are They Enough? Indian Journal of Endocrinology and Metabolism, 19, S18. http://dx.doi.org/10.4103/2230-8210.155355
[2]	Yadav, P., Joseph, D., Joshi, P., Sakhi, P., Jha, R. and Gupta, J. (2010) Clinical Profile & Risk Factors in Acute Coronary Syndrome. National Journal of Community Medicine, 1, 150-151.
[3]	Boulon, C., Lafitte, M., Richeboeuf, V., Paviot, B., Pradeau, V., Coste, P., et al. (2006) Prevalence of Metabolic Syndrome after Acute Coronary Syndrome and Its Prognostic Significance. The American Journal of Cardiology, 98, 1429-1434. http://dx.doi.org/10.1016/j.amjcard.2006.07.025
[4]	Deedwania, P. and Gupta, R. (2006) Management Issues in the Metabolic Syndrome. JAPI, 54, 797-810.
[5]	Munjal, Y. and Sarena, A. (2007) Metabolic Syndrome: Assessing Cardiometabolic Risk. JP Publishers.
[6]	Grundy, S.M., Hansen, B., Smith, S.C., Cleeman, J.I. and Kahn, R.A. (2004) Clinical Management of Metabolic Syndrome Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management. Circulation, 109, 551-556. http://dx.doi.org/10.1161/01.CIR.0000112379.88385.67
[7]	Mente, A., Yusuf, S., Islam, S., McQueen, M.J., Tanomsup, S., Onen, C.L., et al. (2010) Metabolic Syndrome and Risk of Acute Myocardial Infarction: A Case-Control Study of 26,903 Subjects from 52 Countries. Journal of the American College of Cardiology, 55, 2390-2398. http://dx.doi.org/10.1016/j.jacc.2009.12.053
[8]	Lakka, H.-M., Laaksonen, D.E., Lakka, T.A., Niskanen, L.K., Kumpusalo, E., Tuomilehto, J., et al. (2002) The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-Aged Men. JAMA, 288, 2709-2716. http://dx.doi.org/10.1001/jama.288.21.2709
[9]	Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D.S.J., Haffner, S.M., et al. (2003) Metabolic Syndrome with and without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108, 414-419. http://dx.doi.org/10.1161/01.CIR.0000080897.52664.94
[10]	Malik, S., Wong, N.D., Franklin, S.S., Kamath, T.V., Gilbert, J., Pio, J.R., et al. (2004) Impact of the Metabolic Syndrome on Mortality from Coronary Heart Disease, Cardiovascular Disease, and all Causes in United States Adults. Circulation, 110, 1245-1250. http://dx.doi.org/10.1161/01.CIR.0000140677.20606.0E
[11]	Schwartz, G.G., Olsson, A.G., Szarek, M. and Sasiela, W.J. (2005) Relation of Characteristics of Metabolic Syndrome to Short-Term Prognosis and Effects of Intensive Statin Therapy after Acute Coronary Syndrome an Analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Trial. Diabetes Care, 28, 2508-2513. http://dx.doi.org/10.2337/diacare.28.10.2508
[12]	Feinberg, M.S., Schwartz, R., Tanne, D., Fisman, E.Z., Hod, H., Zahger, D., et al. (2007) Impact of the Metabolic Syndrome on the Clinical Outcomes of Non-Clinically Diagnosed Diabetic Patients with Acute Coronary Syndrome. The American Journal of Cardiology, 99, 667-672. http://dx.doi.org/10.1016/j.amjcard.2006.10.023
[13]	National Cholesterol Education Program, National Heart, Lung and Blood Institute (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486-2897. http://dx.doi.org/10.1001/jama.285.19.2486
[14]	Misra, A., Misra, R., Wijesuriya, M. and Banerjee, D. (2007) The Metabolic Syndrome in South Asians: Continuing Escalation & Possible Solutions. Indian Journal of Medical Research, 125, 345-354.
[15]	Cannon, C.P., Battler, A., Brindis, R.G., Cox, J.L., Ellis, S.G., Every, N.R., et al. (2001) American College of Cardiology Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients with Acute Coronary Syndromes: A Report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Emergency Physicians, American Heart Association, Cardiac Society of Australia & New Zealand, National Heart Foundation of Australia, Society for Cardiac Angiography and Interventions, and the Taiwan Society of Cardiology. Journal of the American College of Cardiology, 38, 2114-2130. http://dx.doi.org/10.1016/S0735-1097(01)01702-8
[16]	Jover, A., Corbella, E., Muñoz, A., Millán, J., Pintó, X., Mangas, A., et al. (2011) Prevalence of Metabolic Syndrome and Its Components in Patients with Acute Coronary Syndrome. Revista Española de Cardiología (English Edition), 64, 579-586. http://dx.doi.org/10.1016/j.rec.2011.03.009
[17]	Solymoss, B.C., Bourassa, M.G., Campeau, L., Sniderman, A., Marcil, M., Lespérance, J., et al. (2004) Effect of Increasing Metabolic Syndrome Score on Atherosclerotic Risk Profile and Coronary Artery Disease Angiographic Severity. The American Journal of Cardiology, 93, 159-164. http://dx.doi.org/10.1016/j.amjcard.2003.09.032
[18]	Pilz, S., Scharnagl, H., Tiran, B., Seelhorst, U., Wellnitz, B., Boehm, B.O., et al. (2006) Free Fatty Acids Are Independently Associated with All-Cause and Cardiovascular Mortality in Subjects with Coronary Artery Disease. The Journal of Clinical Endocrinology & Metabolism, 91, 2542-2547. http://dx.doi.org/10.1210/jc.2006-0195
[19]	Nakatani, D., Sakata, Y., Sato, H., Mizuno, H., Shimizu, M., Suna, S., et al. (2007) Clinical Impact of Metabolic Syndrome and Its Additive Effect with Smoking on Subsequent Cardiac Events after Acute Myocardial Infarction. The American Journal of Cardiology, 99, 885-889. http://dx.doi.org/10.1016/j.amjcard.2006.11.033
[20]	Zaliūnas, R., Slapikas, R., Babarskiene, R., Slapikiene, B., Luksiene, D., Milvidaite, I., et al. (2007) The Prevalence of the Metabolic Syndrome Components and Their Combinations in Men and Women with Acute Ischemic Syndromes. Medicina, 44, 521-528.
[21]	Anand, S.S., Islam, S., Rosengren, A., Franzosi, M.G., Steyn, K., Yusufali, A.H., et al. (2008) Risk Factors for Myocardial Infarction in Women and Men: Insights from the INTERHEART Study. European Heart Journal, 29, 932-940. http://dx.doi.org/10.1093/eurheartj/ehn018
[22]	BirhanYilmaz, M., Guray, U., Guray, Y., Altay, H., Demirkan, B., Caldir, V., et al. (2005) Metabolic Syndrome Is Associated with Extension of Coronary Artery Disease in Patients with Non-ST Segment Elevation Acute Coronary Syndromes. Coronary Artery Disease, 16, 287-292. http://dx.doi.org/10.1097/00019501-200508000-00005
[23]	Levantesi, G., Macchia, A., Marfisi, R., Franzosi, M.G., Maggioni, A.P., Nicolosi, G.L., et al. (2005) Metabolic Syndrome and Risk of Cardiovascular Events after Myocardial Infarction. Journal of the American College of Cardiology, 46, 277-283. http://dx.doi.org/10.1016/j.jacc.2005.03.062
[24]	Stamler, J., Vaccaro, O., Neaton, J.D. and Wentworth, D. (1993) Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16, 434-444. http://dx.doi.org/10.2337/diacare.16.2.434
[25]	Das, M., Pal, S. and Ghosh, A. (2010) Association of Metabolic Syndrome with Obesity Measures, Metabolic Profiles, and Intake of Dietary Fatty Acids in People of Asian Indian Origin. Journal of Cardiovascular Disease Research, 1, 130-135. http://dx.doi.org/10.4103/0975-3583.70911
[26]	Kamble, P., Deshmukh, P.R. and Garg, N. (2010) Metabolic Syndrome in Adult Population of Rural Wardha, Central India. The Indian Journal of Medical Research, 132, 701-705.
[27]	Pemminati, S., Adhikari, P.M., Pathak, R. and Pai, M. (2010) Prevalence of Metabolic Syndrome (METS) Using IDF 2005 Guidelines in a Semi Urban South Indian (Boloor Diabetes Study) Population of Mangalore. Journal of Association Physicians of India, 58, 674-677.
[28]	Deepa, M., Farooq, S., Datta, M., Deepa, R. and Mohan, V. (2007) Prevalence of Metabolic Syndrome Using WHO, ATPIII and IDF Definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes/Metabolism Research and Reviews, 23, 127-134. http://dx.doi.org/10.1002/dmrr.658
[29]	Al-Rasadi, K., Sulaiman, K., Panduranga, P. and Al-Zakwani, I. (2011) Prevalence, Characteristics, and In-Hospital Outcomes of Metabolic Syndrome among Acute Coronary Syndrome Patients from Oman. Angiology, 62, 381-389. http://dx.doi.org/10.1177/0003319710382419
[30]	Rajbhandari, A., Pandeya, D.R., Bhattarai, M.D., Malla, R., Sharma, A., Shrestha, D., et al. (2015) Prevalence of Metabolic Syndrome and Its Component in Patients with Acute Coronary Syndrome. Medical Journal of Shree Birendra Hospital, 12, 42-48. http://dx.doi.org/10.3126/mjsbh.v12i2.12928
[31]	Enas, E.A., Chacko, V., Pazhoor, S.G., Chennikkara, H. and Devarapalli, H.P. (2007) Dyslipidemia in South Asian Patients. Current Atherosclerosis Reports, 9, 367-374. http://dx.doi.org/10.1007/s11883-007-0047-y